These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 24664099)

  • 21. Liposome-mediated delivery of the p21 activated kinase-1 (PAK-1) inhibitor IPA-3 limits prostate tumor growth in vivo.
    Al-Azayzih A; Missaoui WN; Cummings BS; Somanath PR
    Nanomedicine; 2016 Jul; 12(5):1231-1239. PubMed ID: 26949163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Motility of select ovarian cancer cell lines: effect of extra-cellular matrix proteins and the involvement of PAK2.
    Flate E; Stalvey JR
    Int J Oncol; 2014 Oct; 45(4):1401-11. PubMed ID: 25050916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PAK1 inhibitor IPA-3 mitigates metastatic prostate cancer-induced bone remodeling.
    Verma A; Artham S; Alwhaibi A; Adil MS; Cummings BS; Somanath PR
    Biochem Pharmacol; 2020 Jul; 177():113943. PubMed ID: 32240651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blockage of PAK1 alleviates the proliferation and invasion of NSCLC cells via inhibiting ERK and AKT signaling activity.
    Song P; Song B; Liu J; Wang X; Nan X; Wang J
    Clin Transl Oncol; 2021 Apr; 23(4):892-901. PubMed ID: 32974862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p21-activated kinase inhibitors.
    Rudolph J; Crawford JJ; Hoeflich KP; Chernoff J
    Enzymes; 2013; 34 Pt. B():157-80. PubMed ID: 25034104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein kinase D1 (PKD1) phosphorylation on Ser
    Chang JK; Ni Y; Han L; Sinnett-Smith J; Jacamo R; Rey O; Young SH; Rozengurt E
    J Biol Chem; 2017 Jun; 292(23):9523-9539. PubMed ID: 28408623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibiting p21-Activated Kinase Induces Cell Death in Vestibular Schwannoma and Meningioma via Mitotic Catastrophe.
    Mercado-Pimentel ME; Miller C; Rolph DN; Villalobos EF; Dunn AM; Mohan PM; Igarashi S; Liu X; Yrun-Duffy M; Patel NK; Read CM; Francis RH; Lane AI; Murugesh S; Jacob A
    Otol Neurotol; 2017 Jan; 38(1):139-146. PubMed ID: 27755359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alphaherpesviral US3 kinase induces cofilin dephosphorylation to reorganize the actin cytoskeleton.
    Jacob T; Van den Broeke C; van Troys M; Waterschoot D; Ampe C; Favoreel HW
    J Virol; 2013 Apr; 87(7):4121-6. PubMed ID: 23365433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PAK'n it in: identification of a selective PAK inhibitor.
    Bokoch GM
    Chem Biol; 2008 Apr; 15(4):305-6. PubMed ID: 18420134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. β-elemene enhances the radiosensitivity of gastric cancer cells by inhibiting Pak1 activation.
    Liu JS; Che XM; Chang S; Qiu GL; He SC; Fan L; Zhao W; Zhang ZL; Wang SF
    World J Gastroenterol; 2015 Sep; 21(34):9945-56. PubMed ID: 26379399
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p21-Activated kinases as promising therapeutic targets in hematological malignancies.
    Wu A; Jiang X
    Leukemia; 2022 Feb; 36(2):315-326. PubMed ID: 34697424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of p21 activated kinase (PAK) reduces airway responsiveness in vivo and in vitro in murine and human airways.
    Hoover WC; Zhang W; Xue Z; Gao H; Chernoff J; Clapp DW; Gunst SJ; Tepper RS
    PLoS One; 2012; 7(8):e42601. PubMed ID: 22900031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PAK1 and PAK2 in cell metabolism regulation.
    Kořánová T; Dvořáček L; Grebeňová D; Röselová P; Obr A; Kuželová K
    J Cell Biochem; 2022 Feb; 123(2):375-389. PubMed ID: 34750857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amyloid-β induced membrane damage instigates tunneling nanotube-like conduits by p21-activated kinase dependent actin remodulation.
    Dilna A; Deepak KV; Damodaran N; Kielkopf CS; Kagedal K; Ollinger K; Nath S
    Biochim Biophys Acta Mol Basis Dis; 2021 Dec; 1867(12):166246. PubMed ID: 34403739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitors of p21-activated kinases (PAKs).
    Rudolph J; Crawford JJ; Hoeflich KP; Wang W
    J Med Chem; 2015 Jan; 58(1):111-29. PubMed ID: 25415869
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined inhibition of receptor tyrosine and p21-activated kinases as a therapeutic strategy in childhood ALL.
    Siekmann IK; Dierck K; Prall S; Klokow M; Strauss J; Buhs S; Wrzeszcz A; Bockmayr M; Beck F; Trochimiuk M; Gottschling K; Martens V; Khosh-Naucke M; Gerull H; Müller J; Behrmann L; Blohm M; Zahedi RP; Jeremias I; Sickmann A; Nollau P; Horstmann MA
    Blood Adv; 2018 Oct; 2(19):2554-2567. PubMed ID: 30301811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of p21-activated kinase 1 attenuates the cardinal features of asthma through suppressing the lymph node homing of dendritic cells.
    Lu M; Xu C; Zhang Q; Wu X; Tang L; Wang X; Wu J; Wu X
    Biochem Pharmacol; 2018 Aug; 154():464-473. PubMed ID: 29906467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LCH-7749944, a novel and potent p21-activated kinase 4 inhibitor, suppresses proliferation and invasion in human gastric cancer cells.
    Zhang J; Wang J; Guo Q; Wang Y; Zhou Y; Peng H; Cheng M; Zhao D; Li F
    Cancer Lett; 2012 Apr; 317(1):24-32. PubMed ID: 22085492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 2-amino-N-{4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-phenyl} acetamide (OSU-03012), a celecoxib derivative, directly targets p21-activated kinase.
    Porchia LM; Guerra M; Wang YC; Zhang Y; Espinosa AV; Shinohara M; Kulp SK; Kirschner LS; Saji M; Chen CS; Ringel MD
    Mol Pharmacol; 2007 Nov; 72(5):1124-31. PubMed ID: 17673571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. P21 activated kinase-1 mediates transforming growth factor β1-induced prostate cancer cell epithelial to mesenchymal transition.
    Al-Azayzih A; Gao F; Somanath PR
    Biochim Biophys Acta; 2015 May; 1853(5):1229-39. PubMed ID: 25746720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.